Monitor for upcoming pricing and trading commencement announcement; absence of disclosed terms means immediate financial impact is limited, but liquidity event is now imminent.
Price Chart
Executive Summary
Propanc Biopharma's IPO registration has become effective, allowing the company to begin selling shares to the public. This follows the S-1 filing and amendments, marking a key milestone toward potential Nasdaq listing.
Key Facts
- IPO registration (Form S-1) has become effective as of April 20, 2026
- The company can now legally offer and sell shares to the public
- This is a standard EFFECT notice with no new financial terms disclosed
- Follows prior S-1 and S-1/A filings indicating an upcoming IPO
Financial Impact
IPO offering size and pricing not disclosed in this filing; potential future dilution possible upon share issuance
Risk Factors
- Small market cap ($3M) increases volatility risk upon listing
- No disclosed offering size or use of proceeds increases uncertainty
- Biotech pre-revenue profile carries high development and funding risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001258 |
| Document: 9999999995-26-001258-index.html | 9999999995-26-001258 |
| Document: 9999999995-26-001258.txt | 9999999995-26-001258 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | Press Release | $0.2800 | awaiting T+5 | — | — |
Oct 5, 2026 21d ago | S-1 | $0.4913 $0.4125 | ▲ +16.04% | ▲ +15.90% | — |
Sep 29, 2026 27d ago | Press Release | $0.5123 $0.4913 | ▼ −4.10% | ▼ −6.05% | — |
Aug 18, 2026 9w ago | Press Release | $1.16 $1.13 | ▼ −2.59% | ▼ −2.39% | — |
Jul 14, 2026 14w ago | 8-K | $1.63 $1.44 | ▼ −11.66% | ▼ −10.68% | — |
May 19, 2026 22w ago | Press Release | $2.01 $1.62 | ▼ −19.20% | ▼ −21.45% | — |
May 15, 2026 23w ago | Press Release | $1.70 $1.76 | ▲ +3.53% | ▲ +2.57% | — |
May 13, 2026 23w ago | Press Release | $1.83 $1.73 | ▼ −5.34% | ▼ −4.62% | — |
Apr 21, 2026 26w ago | EFFECT | $2.83 $2.65 | ▼ −6.28% | ▼ −7.36% | — |
Mar 24, 2026 30w ago | Press Release | $2.77 $2.65 | ▼ −4.33% | ▼ −3.91% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers